Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
07:30:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 6,389.00 JPY | +0.65% |
|
+2.67% | +32.14% |
| Market Cap | 10,202B 65.06B 58.1B 53.67B 48.64B 91B 6,176B 92.5B 646B 256B 3,236B 244B 239B | P/E 2027 * |
50.6x | P/E 2028 * | 32.1x |
|---|---|---|---|---|---|
| Enterprise Value | 14,109B 89.98B 80.35B 74.23B 67.27B 126B 8,542B 128B 893B 354B 4,475B 338B 330B | EV / Sales 2027 * |
3x | EV / Sales 2028 * | 2.9x |
| Free-Float |
99.18% | Yield 2027 * |
3.2% | Yield 2028 * | 3.26% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
OTC Markets
| TKPHF | Delayed | |
Tradegate
| TKD | Real-time | |
Boerse Muenchen
| TKD | Real-time | |
Deutsche Boerse AG
| TKD | Delayed | |
Börse Stuttgart
| TKD | Delayed | |
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.65% | ||
| 1 week | +2.67% | ||
| Current month | +10.54% | ||
| 1 month | +7.05% | ||
| 3 months | +16.06% | ||
| 6 months | +19.85% | ||
| Current year | +32.14% |
| 1 week | 6,200 | 6,500 | |
| 1 month | 5,606 | 6,500 | |
| Current year | 4,710 | 6,500 | |
| 1 year | 4,102 | 6,500 | |
| 3 years | 3,852 | 6,500 | |
| 5 years | 2,993 | 6,500 | |
| 10 years | 2,894.5 | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/2024 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Sell | Executive/Senior Manager | -34,535 | 0.0022% | ||
| 02/09/26 | Sell | Chief Technology Officer | -116,191 | 0.0073% | ||
| 19/08/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.65% | +2.67% | +49.00% | +46.67% | 65.06B | ||
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | ||
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | ||
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | ||
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | ||
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | ||
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | ||
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | ||
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | ||
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | ||
| Average | -0.54% | +2.22% | +38.12% | +68.47% | 406.94B | |
| Weighted average by Cap. | -0.24% | +2.66% | +41.12% | +81.56% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,704B 30B 26.79B 24.75B 22.43B 41.96B 2,848B 42.66B 298B 118B 1,492B 113B 110B | 4,796B 30.58B 27.31B 25.23B 22.87B 42.78B 2,903B 43.49B 304B 120B 1,521B 115B 112B |
| Net income | 196B 1.25B 1.12B 1.03B 936M 1.75B 119B 1.78B 12.43B 4.92B 62.27B 4.7B 4.6B | 323B 2.06B 1.84B 1.7B 1.54B 2.88B 196B 2.93B 20.45B 8.1B 102B 7.73B 7.57B |
| Net Debt | 3,907B 24.92B 22.25B 20.56B 18.63B 34.85B 2,366B 35.43B 247B 97.94B 1,239B 93.52B 91.53B | 3,705B 23.63B 21.1B 19.49B 17.66B 33.05B 2,243B 33.59B 235B 92.86B 1,175B 88.67B 86.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | JP¥6,389.00 | +0.65% | 4,435,900 |
| 22/10/26 | JP¥6,348.00 | +0.52% | 4,775,400 |
| 21/10/26 | JP¥6,315.00 | +0.08% | 5,079,500 |
| 20/10/26 | JP¥6,310.00 | +1.06% | 3,771,000 |
| 19/10/26 | JP¥6,244.00 | +0.34% | 3,572,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions


















